Page last updated: 2024-11-02

pirenzepine and Urinary Bladder, Neurogenic

pirenzepine has been researched along with Urinary Bladder, Neurogenic in 2 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Somogyi, GT1
Zernova, GV1
Yoshiyama, M1
Rocha, JN1
Smith, CP1
de Groat, WC1
Stevens, LA1
Chapple, CR1
Chess-Williams, R1

Other Studies

2 other studies available for pirenzepine and Urinary Bladder, Neurogenic

ArticleYear
Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury.
    Neurochemistry international, 2003, Volume: 43, Issue:1

    Topics: Animals; Atropine; Electric Stimulation; Female; Muscarinic Antagonists; Neurotransmitter Agents; Pi

2003
Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Adult; Aged; Benzofurans; Carbachol; Diamines; Dose-Response Relationship, Drug; Female; Humans; In

2007